State of free-radical processes and antioxidant defence of patients with psoriasis and concomitant essential hypertension
DOI:
https://doi.org/10.14739/2310-1210.2016.4.79730Keywords:
Oxidative Stress, Antioxidant Defence, Psoriasis, HypertensionAbstract
Objective: to study the status of free-radical processes and antioxidant protection parameters in patients with psoriasis and concomitant essential hypertension.
Materials and methods. Study of oxidative status was performed in 95 patients who were divided into 3 groups: I group – psoriasis and hypertension – 25 people; II group – 30 patients with psoriasis only and group III – 40 patients with hypertension only. To assess the severity of skin lesions in psoriasis the index Psoriasis Area and Severity Index (PASI) were used. Protein oxidative destruction markers – aldehydephenilhydrazones and ketophenylhydrazones – were determined under method of B. Halliwell.
Results. Processes of carbonyl stress in the surveyed patients were studied taking into account the level of thiol-disulfide balance. Both spontaneous and stimulated aldehyde phenylhydrazone were the lowest in patients with essential hypertension, in patients with psoriasis and essential hypertension the studied indicators were higher by 75.35 % and 22.03 % (p<0.05) respectively, in patients with psoriasis – by 123.94 % and 47.55 % (p<0.05), respectively, than in case of hypertension. Increase of spontaneous and stimulated ketone phenylhydrazone has also been observed in the main group. In case of psoriasis without essential hypertension the considered indicators exceed the respective values of persons with essential hypertension by 123 % and 64.16 % (p<0.05), respectively, with the presence of essential hypertension – the difference with essential hypertension was only 67.83 % and 28.32 % (p<0.05), respectively. So, patients with psoriasis and essential hypertension had more obvious changes of indicators stipulating the progressive increase of carbonyl stress processes.
Conclusions. Thus, patients with combined pathology – psoriasis and essential hypertension – have development of oxidative and carbonyl stresses which significantly shift thiol-disulfide balance toward oxidized thiols.
Obtained results showed the activation of oxidative stress in case of the studied comorbid pathology and also complex and ambiguous system of regulation of pro- and antioxidant balance which are presented by increase of free-radical oxidation activity and decrease of physiological antioxidant defence.
References
Peluso, I., Cavaliere, A., & Palmery, M. (2016) Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis. J Biomed Sci., 4, 23(1), 52. doi: 10.1186/s12929-016-0268-x.
Borska, L., Andrys, C., Krejsek, J., Palicka, V., Chmelarova, M., Hamakova, K., et al. (2014) Oxidative damage to nucleic acids and benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and chromosomal aberration in children with psoriasis repeatedly exposed to crude coal tar ointment and UV radiation. Oxid Med Cell Longev., 2014, 302528. doi: 10.1155/2014/302528.
Gubskij, Yu. I., Belenichev, I. F., Levickij, E. L., & Pavlov, S. V. (2005) Toksikologicheskie posledstviya okislitel´noij modifikacii belkov pri razlichnykh patologicheskykh sostoyaniyakh [Toxicological consequences of protein oxidative modification in case of different pathological states]. Sychasni problemy toksikolohii, 3, 20–26. [in Ukrainian].
Lin, X., & Huang, T. (2016) Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res., 50(6), 585–95. doi: 10.3109/10715762.2016.1162301.
Sirenko, Yu. M. (2011) Hipertonichna khvoroba i arterialni hipertenzii [Essential hypertension and arterial hypertensions]. Donetsk: Zaslavskyi O. Yu. [in Ukrainian].
Gu, X., Nylander, E., & Coates, P. J. (2015) Oxidation reduction is a key process for successful treatment of psoriasis by narrow-band UVB phototherapy. Acta Derm Venereol., 95(2), 140–6. doi: 10.2340/00015555-1905.
Bakry, O. A., El Hefnawy, S., & Mariee, A. H. (2016) Urinary Biopyrrins: A New Marker of Oxidative Stress in Psoriasis. Indian J Dermatol., 61(2), 169–73. doi: 10.4103/0019-5154.177756.
Schesnokova, N. P., Ponikalina, E. V., & Bizenkova, M. N. (2006) Melokulyarno-kletochnye mekhanizsmy inaktivacii svobodnykh radikalov v biologicheskikh sistemakh [Molecular-cellular mechanisms of inactivation of free radicals in biological systems]. Uspekhi sovremennogo estestvoznaniya, 7, 29–36. [in Russian].
Nemati, H., Khodarahmi, R., Sadeghi, M., Ebrahimi, A., Rezaei, M., & Vaisi-Raygani, A. (2014) Antioxidant status in patients with psoriasis. Cell Biochem Funct., 32(3), 268–273. doi: 10.1002/cbf.3011.
Doroshuk, A. D. (2007) Strukturno-funkcionalnye osobennosti mitokhondrij pri e´xperimental´noj gepertonii razlichnogo geneza (Dis… dokt. biol. nauk). [Structural and functional features of mitochonria in case of experimental hypertension of different genesis. Dr. biol. sci. diss.]. Мoscow. [in Russian].
Yazici, C., Köse, K., Utaş, S., Tanrikulu, E., & Taşlidere, N. (2016) A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress. Arch Dermatol Res., 308(3), 207–12. doi: 10.1007/s00403-016-1624-0.
Menshikova, E. B., Zenkov, N. K., Lankin, V. Z., et al. (2008) Okislitel´nyj stress: patologicheskie sostoyaniya i zabolevaniya [Oxidative stress: pathological states and diseases]. Novosibirsk: ARTA. [in Russian].
Asefi, M., Vaisi-Raygani, A., Khodarahmi, R., Nemati, H., Rahimi, Z., Vaisi-Raygani, H. et al. (2014) Methylentetrahydrofolatereductase (rs1801133) polymorphism and psoriasis: contribution to oxidative stress, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report. J Eur Acad Dermatol Venereol., 28(9), 1192-8. doi: 10.1111/jdv.12262.
Rajappa, M., Shanmugam, R., Munisamy, M., Chandrashekar, L., Rajendiran, K., & Thappa, D. M. (2016) Effect of antipsoriatic therapy on oxidative stress index and sialic acid levels in patients with psoriasis. Int J Dermatol., 55(8), e422-30. doi: 10.1111/ijd.13196.
Menshikova, E. B., Zenkov, N. K., & Lankin, V. Z. (2006) Okislitelnyi stress: perooksidanty i antioksidanty [Oxidative stress: Peroxides and antioxidants]. Moscow: Slovo. [in Russian].
Elango, T., Dayalan, H., Gnanaraj, P., Malligarjunan H., & Subramanian, S. (2014) Impact of methotrexate on oxidative stress and apoptosis markers in psoriatic patients. Clin Exp Med., 14(4), 431–7. doi: 10.1007/s10238-013-0252-7.
Sezer, U., Şenyurt, S. Z., Gündoğar, H., Erciyas, K., Üstün, K., Kimyon, G., et al. (2016) Effect of Chronic Periodontitis on Oxidative Status in Patients With Psoriasis and Psoriatic Arthritis. J Periodontol, 87(5), 557–65. doi: 10.1902/jop.2015.150337.
Kolesnik, Yu. M., Belenichev, I. F., & Gancheva, O. V. (2005) Signal´naya rol´ aktivnykh form kisloroda v regulyacii fiziologicheskikh funkcij [Signal role of reactive oxygen species in regulation of physiological functions]. Patologiya, 2(1), 4–10. [in Ukrainian].
Aydin, E. Karabacak, E., Ozcan, O., & Dinc, M. et al. (2013) Comment on "Serum methylglyoxal level and its association with oxidative stress and disease severity in patients with psoriasis". Arch Dermatol Res., 305(7), 671–2. doi: 10.1007/s00403-013-1400-3.
Sunitha, S., Rajappa, M., & Thappa, D. M. (2015) Comprehensive lipid tetrad index, atherogenic index and lipid peroxidation: Surrogate markers for increased cardiovascular risk in psoriasis. Indian J Dermatol Venereol Leprol., 81(5), 464–71. doi: 10.4103/0378-6323.163734.
Kilic, S., Emre, S., Metin, A., Isikoglu, S., & Erel, O. (2013) Effect of the systemic use of methotrexate on the oxidative stress and paraoxonase enzyme in psoriasis patients. Arch Dermatol Res., 305(6), 495–500. doi: 10.1007/s00403-013-1366-1.
Golikov, A. P., Boitsov, S. A., & Mikhin, V. P. (2003) Svobodno-radikalnoe okislenie i serdechno-sosudistaya patologiya: korrekciya antioksidantami [Free-radical oxidation and cardiovascular pathology: correction with antioxidants]. Lechaschij vrasch, 4, 70–74. [in Russian].
Matoshvili, M., Katsitadze, A., Sanikidze, T., Tophuria, D., D'Epiro, S., & Richetta, A. (2015) Evaluation of blood redox-balance, nitric oxide content and CCR6 in the genetic susceptibility during psoriasis. Georgian Med News., 240, 37–43.
Kaur, S., Zilmer, K., Leping, V., & Zilmer, M. (2013) Serum methylglyoxal level and its association with oxidative stress and disease severity in patients with psoriasis. Arch Dermatol Res., 305(6), 489–94. doi: 10.1007/s00403-013-1362-5.
Ikonomidis, I., Makavos, G., Papadavid, E. et al. (2015) Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: the role of oxidative stress and inflammation. Can J Cardiol., 31(3), 287–95. doi: 10.1016/j.cjca.2014.11.002.
Bacchetti, T., Campanati, A., Ferretti, G., Simonetti, O., Liberati, G., & Offidani, A. M. (2013) Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment. Br J Dermatol., 168(5), 984–9. doi: 10.1111/bjd.12144.
Karbach, S., Croxford, A. L., Oelze, M., Schüler, R., Minwegen, D., Wegner, J., et al. (2014) Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol., 34(12), 2658–68. doi: 10.1161/ATVBAHA.114.304108.
Karababa, F., Yesilova, Y., Turan, E., Selek, S., Altun, H., & Selek, S. (2013) Impact of depressive symptoms on oxidative stress in patients with psoriasis. Redox Rep., 18(2), 51–5. doi: 10.1179/1351000213Y.0000000039.
Ozdemir, M., Kiyici, A., Balevi, A., Mevlitoğlu, I., & Peru, C. (2012) Assessment of ischaemia-modified albumin level in patients with psoriasis. Clin Exp Dermatol., 37(6), 610–4. doi: 10.1111/j.1365-2230.2012.04384.x.
Lyakhovych, V. V., Vavilin, V. A., Zenkov, N. K. et al. (2006) Aktivnaya zaschita pri okistitel´nom stresse. Antioksidant-responsivnyj e´lement [Active protection in case of oxidative stress. Antioxidant-responsive element]. Biokhimiya, 71(9), 1183–1197. [in Russian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
